相关实验视频

Updated: Jul 8, 2025

Analysis of Hematopoietic Stem Progenitor Cell Metabolism

Analysis of Hematopoietic Stem Progenitor Cell Metabolism

Published on: November 9, 2019

通过抑制氧化酸化,可以消除IDH1-突变的白血病前造血干细胞

Niklas Landberg¹, Thomas Köhnke¹, Yang Feng²

¹Stanford University School of Medicine, Stanford, California, United States.

Blood cancer discovery

|December 13, 2023

概括

针对具有IDH1突变的前白血病干细胞 (PSC) 可以预防白血病. 抑制它们的氧化酸化消除了IDH1-突变PSCs,为急性髓性白血病 (AML) 复发预防提供了一种新的治疗策略.

科学领域:

血液学血液学血液学
癌症生物学癌症生物学
干细胞生物学干细胞生物学

背景情况:

在急性髓性白血病 (AML) 诊断时,具有发病突变的罕见前白血病造血干细胞 (pHSC) 存在.
这些pHSC是白血病的起源,可以导致复发.
了解pHSC生物学对于开发向疗法至关重要.

研究的目的:

研究IDH1-突变pHSC和健康的造血干细胞 (HSC) 之间的差异.
确定IDH1-突变pHSCs的潜在治疗漏洞.
探索预防白血病发展和复发的策略.

主要方法:

利用原始人类样本和基因编辑来建模IDH1-突变pHSCs.
分析了pHSCs和HSCs的表观遗传,转录和代谢概况.
评估了氧化酸化抑制对IDH1-突变pHSCs的影响.

主要成果:

与野生类型的HSC相比,IDH1-突变的pHSC表现出明显的表观遗传,转录和代谢特征.
IDH1-突变的pHSCs表现出减少的增殖,阻断的分化和改变的新陈代谢,包括氧化酸化重编程.
抑制氧化酸化专门消除了IDH1-突变pHSCs,但不是IDH2-突变pHSCs或野生型HSCs.
IDH1驱动的克隆造血与细胞衰减有关,这表明造血复合功能受损.

结论:

IDH1-突变pHSC具有独特的代谢脆弱性,特别是在氧化酸化中.
用复杂I抑制剂向氧化酸化为消除IDH1-突变pHSCs的有希望的策略.
这种方法可以防止源自IDH1-突变克隆的AML的发展和复发.

更多相关视频

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

Published on: September 5, 2019

Assessment of Cellular Bioenergetics in Mouse Hematopoietic Stem and Primitive Progenitor Cells using the Extracellular Flux Analyzer

Assessment of Cellular Bioenergetics in Mouse Hematopoietic Stem and Primitive Progenitor Cells using the Extracellular Flux Analyzer

Published on: September 24, 2021

相关概念视频

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...